{"id":"W4411394482","doi":"10.1016/j.ard.2025.05.117","title":"OP0095 Efficacy and safety of deucravacitinib up to week 52 from POETYK PsA-2: a multicenter, randomized, double-blind, placebo-controlled, phase 3 study in patients with psoriatic arthritis","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Psoriatic arthritis; Placebo; Double blind; Multicenter study; Internal medicine; Arthritis; Randomized controlled trial; Dermatology; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001527108,0.001381938,0.002648137,0.0004750446,0.0005139438,0.001098039,0.0009853274,0.001647485,0.004933992],"category_scores_gemma":[0.0009688405,0.0006380633,0.001828316,0.0004281531,0.001066224,0.00130895,0.0004044971,0.00378185,0.001026572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008648414,"about_ca_system_score_gemma":0.001506229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005961682,"about_ca_topic_score_gemma":0.002114601,"domain_scores_codex":[0.9993334,0.0002204821,0.00005662329,0.0001528377,0.00009934001,0.0001373254],"domain_scores_gemma":[0.9992146,0.0001140082,0.0002248546,0.00005489836,0.00006955513,0.0003219225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.863538,0.05087393,0.002516745,0.001295337,0.001221196,0.0001240914,0.0001465193,0.000990008,0.02539922,0.0001174956,0.002230178,0.05154732],"study_design_scores_gemma":[0.7089846,0.2784137,0.008016194,0.00003217585,0.000461237,0.0001239068,0.00002612176,0.000572197,0.002217534,0.00009142388,0.001025845,0.00003504446],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901112,0.003250047,0.0005086712,0.000326911,0.0001809183,0.002811525,0.001059824,0.0001697643,0.001581096],"genre_scores_gemma":[0.9915489,0.001103182,0.001001864,0.0006815328,0.0002141441,0.002143405,0.001619185,0.00002999555,0.001657771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004933992,"threshold_uncertainty_score":0.01650584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02392155826949975,"score_gpt":0.2943720277713867,"score_spread":0.2704504695018869,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}